We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
FIT Biotech granted U.S. patent for treating HIV The patent grants the Company exclusive rights to exploit its GTU®-based DNA vaccines, including FIT-06, for the treatment of HIV patients.